Redx Pharma PLC
LSE:REDX
Redx Pharma PLC
Revenue
Redx Pharma PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
R
|
Redx Pharma PLC
LSE:REDX
|
Revenue
£4.2m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
101%
|
CAGR 10-Years
N/A
|
GlaxoSmithKline PLC
LSE:GSK
|
Revenue
£30.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
AstraZeneca PLC
LSE:AZN
|
Revenue
$47.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
6%
|
|
Indivior PLC
LSE:INDV
|
Revenue
$1.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Revenue
$2.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Revenue
£761.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
See Also
What is Redx Pharma PLC's Revenue?
Revenue
4.2m
GBP
Based on the financial report for Sep 30, 2023, Redx Pharma PLC's Revenue amounts to 4.2m GBP.
What is Redx Pharma PLC's Revenue growth rate?
Revenue CAGR 5Y
101%
Over the last year, the Revenue growth was -78%. The average annual Revenue growth rates for Redx Pharma PLC have been -10% over the past three years , 101% over the past five years .